Ultragenyx to Present at Piper Sandler Healthcare Conference
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that CEO Emil D. Kakkis will present at the Piper Sandler Annual Healthcare Conference on November 29, 2022, at 10:00 AM ET in New York.
The live presentation and archived webcast will be available on the company’s website for 120 days. Ultragenyx is dedicated to developing therapies for serious rare and ultra-rare genetic diseases, focusing on unmet medical needs with a diverse portfolio of treatments.
- None.
- None.
NOVATO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer and President, will present at the Piper Sandler Annual Healthcare Conference on Tuesday, November 29, 2022, at 10:00 AM ET in New York.
The live and archived webcast of the presentation will be accessible from the company’s website at http://ir.ultragenyx.com/events.cfm. The replay of the webcast will be available for 120 days.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
Contacts
Ultragenyx Pharmaceutical, Inc.
Investors
Joshua Higa
ir@ultragenyx.com
Media
Jeff Blake
415-612-7784
media@ultragenyx.com
FAQ
What is the date of Ultragenyx's presentation at the Piper Sandler Annual Healthcare Conference?
Who will present at the Piper Sandler Annual Healthcare Conference for Ultragenyx?
What time is Ultragenyx's presentation at the conference?
Where can I access the webcast of Ultragenyx's presentation?
How long will the webcast of Ultragenyx's presentation be available?
What is the focus of Ultragenyx Pharmaceutical Inc.?
What is the stock symbol for Ultragenyx Pharmaceutical Inc.?
